ARCHIVES

FDA Approves Avastin For Recurrent NSCLC

This article is from The Cancer Letter archive.

Vol. 29 No. 10 | October 27, 2006

Download PDF Visit The Full Archive

Related Articles

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

January 4, 2002

Surveillance Treatment Option For Low-Risk Prostate Cancer

July 30, 2010

Afinitor Extends PFS In Women With EGFR-2 Positive Disease

June 28, 2013

Pryor Bill Embodies Drug Company Fears

July 8, 1994

Attempt To Push NCI To Establish Diagnostic Coordinating Group Fails

July 5, 1974

In Brief: NIH Budget Cut Being Considered, Threatening NCI’s Plan For Reaching Year 2000 Goals

December 13, 1984